CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 89 filers reported holding CTI BIOPHARMA CORP in Q2 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $120,000 | +2.6% | 297,000 | -4.8% | 0.00% | – |
| Q3 2016 | $117,000 | +3.5% | 312,100 | -6.4% | 0.00% | – |
| Q2 2016 | $113,000 | -38.3% | 333,500 | -3.0% | 0.00% | – |
| Q1 2016 | $183,000 | -59.2% | 343,900 | -5.7% | 0.00% | -100.0% |
| Q4 2015 | $449,000 | -15.6% | 364,700 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $532,000 | -25.2% | 364,700 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $711,000 | -12.5% | 364,700 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $813,000 | 0.0% | 364,700 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $813,000 | -7.9% | 364,700 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $883,000 | -13.9% | 364,700 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,025,000 | – | 364,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|